(Q35151329)

6 August 2017

1 reference

title

Management of neuropathy and foot problems in diabetic patients (English)

1 reference

6 August 2017

Aaron I Vinik

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

38-55

1 reference

Costs and duration of care for lower extremity ulcers in patients with diabetes

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Assessment and management of foot disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Diabetic neuropathy: pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Mortality in diabetic patients with cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Entrapment neuropathies of the upper extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Diagnosis and management of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

The clinical spectrum of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Evaluation of somatic and autonomic small fibers neuropathy in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis)

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Uncommon early-onset neuropathy in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Clinical aspects of diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Quantitative measurement of cutaneous perception in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Nerve biopsy findings in different patterns of proximal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Quantitation of epidermal nerves in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Painful sensory neuropathy: prospective evaluation using skin biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Autoimmune diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Successful treatment of neuropathies in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Calcitonin nasal spray for painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990017-2

7 January 2021

10.1016/S1098-3597(03)90017-2

Identifiers

DOI

1 reference

6 August 2017

1 reference